Skip to content

TransMedics Group, Inc. TMDX Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin59.1%-0.4pp59.9%+0.6pp60.3%+0.9pp59.8%-0.9pp59.5%-2.9pp
Operating margin14.9%+4.1pp17.9%+9.4pp16.9%+9.7pp14.4%+15.4pp10.8%+16.4pp
Net margin27%31.4%16.2%
Returns
Return on equity45.2%54.2%32.5%
Efficiency
Asset turnover0.6×-0.1×0.6×+0.1×0.7×+0.1×0.6×+0.1×0.6×0.0×
Liquidity
Current ratio6.7×-2.4×7.1×-1.2×7.7×-0.5×9.9×+0.5×9.1×-0.6×
Leverage
Debt-to-equity0.8×+0.6×0.1×-0.2×0.2×-0.1×0.2×-0.1×0.3×-0.2×
Net debt / EBITDA-0.4×+2.9×-3.1×-3.3×-3.3×-3.3×
Per Share
Book value per share$13.65+105%$11.67+79.8%$8.72+48.2%$7.84+45.7%$6.67+45.1%
Valuation
Market capitalization$3.41B+50.6%$4.16B+98.7%$3.82B-27.1%$4.49B-10.0%$2.26B-6.5%
Price / earnings19.8×21.8×41.7×
Price / sales5.4×+0.7×6.9×+2.1×6.8×-6.3×8.4×-5.5×4.6×-3.5×
Price / book6.9×-1.6×8.8×-0.4×10.8×-14.2×14.1×-12.2×8.5×-6.7×
EV / EBITDA26.4×-0.9×27.5×28.2×41.4×27.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are TransMedics Group, Inc.'s profit margins?
TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.
Where do TransMedics Group, Inc.'s ratios come from?
Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.